ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding ClearPoint Neuro, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 78 | −7 |
| Shares | 7.06M | 366.4K | 6.82M | +136.1K (+2.0%) |
| Value | $38.0M | $1.97M | $76.5M | +$40.4M (+112.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held ClearPoint Neuro, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 371,601 | $4.17M | 0.00% |
| Conway Capital Management, Inc. | 141,500 | $1.59M | 0.77% |
| EAM Investors, LLC | 78,992 | $885.5K | 0.13% |
| Pekin Hardy Strauss, Inc. | 48,250 | $540.9K | 0.07% |
| Ameriprise Financial Inc | 38,574 | $432.4K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 32,661 | $366.1K | 0.00% |
| GWM Advisors LLC | 19,683 | $220.6K | 0.00% |
| Aster Capital Management (DIFC) Ltd | 17,500 | $196.2K | 0.04% |
| Oppenheimer & Co Inc | 13,929 | $156.1K | 0.00% |
| Lazard Asset Management LLC | 13,673 | $153.0K | 0.00% |
| Verition Fund Management LLC | 11,000 | $123.3K | 0.00% |
| Oarsman Capital, Inc. | 5,000 | $56.0K | 0.01% |
| Acadian Asset Management LLC | 3,768 | $42.0K | 0.00% |
| Dunhill Financial, LLC | 1,500 | $16.8K | 0.01% |
| National Bank of Canada | 274 | $3.07K | 0.00% |
Sold out (22)
Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 79,650 | $429.3K |
| Rinkey Investments | 57,015 | $307.3K |
| Schonfeld Strategic Advisors LLC | 27,234 | $146.8K |
| HRT Financial LP | 27,062 | $145.0K |
| Corton Capital Inc. | 24,494 | $132.0K |
| Bank of Montreal | 22,011 | $125.2K |
| Paloma Partners Management Co | 22,500 | $121.3K |
| Virtu Financial LLC | 19,572 | $105.0K |
| Sherbrooke Park Advisers LLC | 17,181 | $92.6K |
| Sentinus, LLC | 14,970 | $80.7K |
| Brevan Howard Capital Management LP | 13,218 | $71.2K |
| Mirae Asset Global ETFs Holdings Ltd. | 11,389 | $61.4K |
| Tower Research Capital LLC (TRC) | 10,681 | $57.6K |
| Federation des caisses Desjardins du Quebec | 8,000 | $43.1K |
| Rhumbline Advisers | 5,759 | $31.0K |
| Macquarie Group Ltd | 1,125 | $6.06K |
| CIBC Private Wealth Group, LLC | 927 | $5.22K |
| Adirondack Trust Co | 880 | $4.74K |
| New York State Common Retirement Fund | 193 | $1.04K |
| Gradient Investments LLC | 145 | $782 |
| GAMMA Investing LLC | 42 | $226 |
| CWM, LLC | 13 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 366,398 | $1.97M |